Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 357-361, January 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Messing, E. M.
Right arrow Articles by Reznikoff, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Messing, E. M.
Right arrow Articles by Reznikoff, C. A.

Normal and Malignant Human Urothelium: In Vitro Response to Blockade of Polyamine Synthesis and Interconversion1

Edward M. Messing2, Patricia Hanson and Catherine A. Reznikoff

Departments of Surgery [E. M. M., P. H.] and Human Oncology [E. M. M., C. A. R.], University of Wisconsin School of Medicine, Madison, Wisconsin 53792

To assess the effect of polyamine blockade on urinary epithelium, growth of normal human urothelial cell cultures and human transitional cell carcinoma (TCC) cell lines in the presence of various inhibitors of polyamine synthesis was evaluated. All four human TCC cell lines tested were quite sensitive to the specific inhibitor of ornithine decarboxylase, {alpha}-difluoromethylornithine (DFMO), requiring ≤1.0 mM DFMO to double generation time. Alternatively, all three human urothelial cultures tested required 5–20-fold higher DFMO concentrations to achieve similar growth inhibition. The inhibitory effect of DFMO on TCC was found to act synergistically with that of the inhibitor of S-adenosylmethionine decarboxylase, methylglyoxal bis(guanylhydrazone), and additively with that of recombinant ß-serine interferon. Addition of individual polyamines entirely prevented the inhibitory effects of DFMO and/or methylglyoxal bis(guanylhydrazone) but not that of ß-serine interferon. It appears that inhibition of polyamine synthesis and/or interconversion holds promise in the management of TCC and that the in vitro model described will be of value in investigating such clinical applications.

1 Supported by Grants CA36908 (E. M. M.), CA44801 (E. M. M.), and CA29525 (C. A. R.) from the NIH.

2 To whom requests for reprints should be addressed.

Received 5/ 5/87. Revised 10/13/87. Accepted 10/16/87.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
E. M. Messing, R. R. Love, K. D. Tutsch, A. K. Verma, J. Douglas, M. Pomplun, R. Simsiman, and G. Wilding
Low-Dose Difluoromethylornithine and Polyamine Levels in Human Prostate Tissue
J Natl Cancer Inst, August 18, 1999; 91(16): 1416 - 1417.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.